Iodamide Meglumine: uses, dosing, side effects & brands
Iodamide Meglumine is a medicine sold in the U.S. under 2 brand and generic names. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Available as
- Injectable
- Sold as
- 2 products — Renovue-65 and Renovue-Dip
- Prescription?
- Prescription only
- Generic available?
- Not in our catalog
Every iodamide meglumine product we track (2)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Injectable | No data | — | View → | |
| 2 | Not yet rated | Prescription | Injectable | No data | — | View → |
What people report to the FDA about iodamide meglumine
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 9 reports naming iodamide meglumine, and the FDA flagged 89% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- abdominal discomfort4 reports
- abdominal distension4 reports
- abdominal pain upper4 reports
- alopecia4 reports
- anti-cyclic citrullinated peptide antibody positive4 reports
- arthralgia4 reports
- arthropathy4 reports
- asthenia4 reports
Read these as a signal, not a rate. A report does not mean iodamide meglumine caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.
Source: openFDA drug/event (FAERS), retrieved July 25, 2026.
Related calculators
Frequently asked questions
Can you take iodamide meglumine with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run iodamide meglumine against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What brand names is iodamide meglumine sold under?
We track 2 iodamide meglumine-containing products in the U.S.: Renovue-65 and Renovue-Dip. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.
What forms does iodamide meglumine come in?
Across the brands we track, iodamide meglumine is currently marketed as injectable, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic iodamide meglumine?
We do not currently list a generic-labelled iodamide meglumine product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.
Cite this page
- APA
- pharmaranks. (2026, July 24). Iodamide Meglumine: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/iodamide-meglumine
- MLA
- “Iodamide Meglumine: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/iodamide-meglumine.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for iodamide meglumine on DailyMed (NIH) ↗.